WASHINGTON, June 26 (Reuters) -- Drugmaker Roche Holding AG will try to convince U.S. regulators to reverse course on Avastin, the world's best-selling cancer medicine, and approve its use for breast ...

Following a request for judicial review by drugmakers Bayer and Novartis, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued a statement clarifying that Roche's Avastin ...

WASHINGTON (AP) - Federal health authorities recommended Thursday that the drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug's original promise to ...

Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...

LOS ANGELES, Oct 11 (Reuters) - Genentech Inc said on Thursday it will ban on Nov. 30 direct purchases of Avastin by independent compounding pharmacies, which repackage the cancer drug as a low-cost ...

I covered the FDA's Oncologic Drugs Advisory Committee this week, which, not surprisingly, turned out to be the most emotional FDA hearing I've covered in my three years on this beat. Not surprising ...

Health care firm Roche announced in a press release Thursday that the FDA has approved a new indication for its cancer drug Avastin. The new usage will allow Roche to market Avastin, in combination ...